Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug
After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug
After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug
Submitted by
admin
on July 10, 2017 - 9:24am
Source:
Endpoints
News Tags:
FDA
clinical trials
Concert Pharmaceuticals
CTP-543
alopecia areata
hair loss
Headline:
After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug
Do Not Allow Advertisers to Use My Personal information